As of the latest SEC filings, Denali Therapeutics Inc. (DNLI) is held by 258 institutional funds. The largest fund shareholder is VANGUARD TOTAL STOCK MARKET INDEX FUND (VTI), holding an estimated $81,439,584.00 in market value, representing a significant portion of its portfolio.
Funds holding Denali Therapeutics Inc. (DNLI)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- DNLI
- CIK:
- 0001714899
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $81,439,584.00 | 4,241,645 | Mar 31, 2026 | May 28, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.09% | $66,650,457.60 | 3,471,378 | Mar 31, 2026 | May 28, 2026 |
|
VWUAX
VANGUARD U.S. GROWTH FUND
|
MF | Vanguard | 0.15% | $64,341,811.26 | 3,037,857 | Feb 28, 2026 | Apr 28, 2026 |
|
NAESX
VANGUARD SMALL-CAP INDEX FUND
|
ETF | Vanguard | 0.04% | $59,740,416.00 | 3,111,480 | Mar 31, 2026 | May 28, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 0.73% | $54,352,396.80 | 2,830,854 | Mar 31, 2026 | May 28, 2026 |
|
OTCFX
T. Rowe Price Small-Cap Stock Fund, Inc.
|
MF | T. Rowe Price | 0.55% | $44,747,942.40 | 2,330,622 | Mar 31, 2026 | May 28, 2026 |
|
SMCWX
SMALLCAP World Fund Inc
|
MF | Independent / Boutique | 0.05% | $42,409,171.20 | 2,208,811 | Mar 31, 2026 | May 28, 2026 |
|
VISGX
VANGUARD SMALL-CAP GROWTH INDEX FUND
|
ETF | Vanguard | 0.09% | $33,367,545.60 | 1,737,893 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.04% | $31,788,825.60 | 1,655,668 | Mar 31, 2026 | May 28, 2026 |
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.04% | $30,805,251.00 | 1,454,450 | Feb 28, 2026 | Apr 24, 2026 |
|
PASVX
T. Rowe Price Small-Cap Value Fund, Inc.
|
MF | T. Rowe Price | 0.29% | $27,065,011.20 | 1,409,636 | Mar 31, 2026 | May 28, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.08% | $26,370,021.60 | 1,408,655 | Apr 30, 2026 | Jun 26, 2026 |
|
TRSSX
T. Rowe Price Institutional Small-Cap Stock Fund
|
MF | T. Rowe Price | 0.56% | $24,470,688.00 | 1,274,515 | Mar 31, 2026 | May 28, 2026 |
|
HQH
abrdn Healthcare Investors
|
CEF | abrdn / Aberdeen | 2.01% | $22,842,816.00 | 1,189,730 | Mar 31, 2026 | May 29, 2026 |
|
IWN
iShares Russell 2000 Value ETF
|
ETF | BlackRock / iShares | 0.18% | $22,072,377.60 | 1,149,603 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.25% | $20,260,032.00 | 1,055,210 | Mar 31, 2026 | May 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.04% | $16,402,681.56 | 774,442 | Feb 28, 2026 | Apr 24, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.07% | $15,221,663.58 | 718,681 | Feb 28, 2026 | Apr 24, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.09% | $13,896,367.44 | 656,108 | Feb 28, 2026 | Apr 28, 2026 |
|
APDJX
Artisan International Small-Mid Fund
|
MF | Independent / Boutique | 0.49% | $13,122,105.60 | 683,443 | Mar 31, 2026 | May 29, 2026 |
|
QUAZX
AB Small Cap Growth Portfolio
|
MF | Independent / Boutique | 0.45% | $13,109,616.00 | 700,300 | Apr 30, 2026 | Jun 24, 2026 |
|
HQL
abrdn Life Sciences Investors
|
CEF | abrdn / Aberdeen | 2.28% | $12,762,547.20 | 664,716 | Mar 31, 2026 | May 29, 2026 |
|
DFSTX
U.S. SMALL CAP PORTFOLIO
|
MF | Dimensional Fund Advisors | 0.07% | $12,717,057.60 | 679,330 | Apr 30, 2026 | Jun 24, 2026 |
|
CHCLX
AB DISCOVERY GROWTH FUND, INC.
|
MF | Independent / Boutique | 0.46% | $12,434,179.68 | 664,219 | Apr 30, 2026 | Jun 24, 2026 |
|
PSBMX
SmallCap Fund
|
MF | Independent / Boutique | 0.52% | $10,958,688.00 | 585,400 | Apr 30, 2026 | Jun 25, 2026 |
Advertisement (320x50)